Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate Solution, Concentrate
NDC Package 52536-177-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate (sodium sulfate, potassium sulfate, magnesium sulfate) solution is sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older. This formulation utilizes a solution, concentrate delivery system. Marketed by Wilshire Pharmaceuticals, Inc., this product is identified by NDC 52536-177 and is authorized under FDA application NDA022372.

Identification & Billing

NDC Package Code
52536-177-01
Package Description
2 BOTTLE, PLASTIC in 1 CARTON / 133.1 mL in 1 BOTTLE, PLASTIC
Product Code
52536-177
11-Digit Billing Format
52536017701
RxNorm Crosswalk
  • RxCUI: 1001689 - {2 (480 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
  • RxCUI: 1001689 - 2 (16 OZ magnesium sulfate 1.6 GM / potassium sulfate 3.13 GM / sodium sulfate 17.5 GM Oral Solution) Pack
  • RxCUI: 1120068 - magnesium sulfate 1.6 GM / potassium sulfate 3.13 GM / sodium sulfate 17.5 GM in 177 mL Oral Solution
  • RxCUI: 1120068 - magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution
  • RxCUI: 1120068 - Magnesium Sulfate 0.0277 MEQ/ML / K+ sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution

Clinical Specifications

Proprietary Name
Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Non-Proprietary Name
Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate
Substance Name
Magnesium Sulfate, Unspecified Form; Potassium Sulfate; Sodium Sulfate
Dosage Form
Solution, Concentrate - A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its nonactive parts.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older.

Regulatory & Marketing

Labeler Name
Wilshire Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA022372
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-15-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52536-177-01 identifies a specific commercial package of 2 bottle, plastic in 1 carton / 133.1 ml in 1 bottle, plastic of Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate, a human prescription drug labeled by Wilshire Pharmaceuticals, Inc.. This solution, concentrate is formulated for oral use and contains magnesium sulfate, unspecified form; potassium sulfate; sodium sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wilshire Pharmaceuticals, Inc. on April 15, 2026. The current certification is valid through December 31, 2027.

How is this Wilshire Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52536017701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52536-177-01
11-Digit CMS (5-4-2)
52536-0177-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.